Abstract:Objective To investigate the migration and invasion behaviors of Hep-2 after the targeted knockdown of yes-associated protein (YAP). Methods Hep-2 cells were knock-downed for YAP by shRNA as YAP-shRNA group, Hep-2 treated with non-specific shRNA as YAP-NC group, and Hep-2 with no treatment as control. Glucose uptake and lactate production in the cells were examined to assess Warburg effect. The migration and invasion behaviors of cells in three groups were observed. The expressions of vimentin and E-cadherin were detected by RT-PCR and Western Blot. The statistical software GraphPad Prism 7.0 was used to analyze significance of data. Two tailed Student' s t-tests was used to determine significance when only two groups were compared. P values of less than 0.05 was considered statistically significant. Results Downregulation of YAP led to a obvious decrease in glucose uptake [(18.51± 1.72)％ ] and lactate production [103.40 ± 8.32] in Hep-2 cells compared with control [(41.20 ± 1.11)％ and 743.69±19.49, t=19.20 and 52.33, respectively, both P<0.01] and YAP-NC group [(39.60±0.78)％ and 705.22± 17.20, t=19.34 and 54.56, respectively, both P<0.01]. Compared with the control group (78.32 ± 4.04) and YAP-NC group (77.28 ± 3.11), the scratch healing ability of Hep-2 cells was significantly decreased in YAP-shRNA group (44.71±4.68). The P value was less than 0.01 (t=9.42 and 10.04). The number of cells with YAP-shRNA (33.30 ± 4.19) passing through compartments was remarkable fewer than the control group (133.71±6.72) and YAP-NC group (126.32±4.21). The P value was less than 0.01 (t=21.96 and 27.13). The expression of E-cadherin protein in cells of YAP-shRNA group (6.16±0.11) was up-regulated compared with control (0.97±0.10, t=35.70, P<0.01) and YAP-NC group (1.13±0.09, t=36.28, P<0.01), while the expression of vimentin protein in cells of YAP-shRNA group (1.08 ± 0.09) was down-regulated compared with control (5.67 ± 0.12, t=29.91, P<0.01) and YAP-NC group (5.51 ± 0.12, t=29.04, P<0.01). Conclusions The down-regulation of YAP in Hep-2 inhibits the migration and invasion of cells via suppressing Warburg and EMT program.

Knockdown of Yes-Associated Protein Inhibits Proliferation and Downregulates Large Tumor Suppressor 1 Expression in MHCC97H Human Hepatocellular Carcinoma Cells

Interleukin-6 Induced by YAP in Hepatocellular Carcinoma Cells Recruits Tumor-Associated Macrophages

Lipolysis-Stimulated Lipoprotein Receptor Impairs Hepatocellular Carcinoma and Inhibits the Oncogenic Activity of YAP1 via PPPY Motif

Targeted-knockdown of Yes-associated protein inhibits the Warburg effect and the invasion of laryngeal cancer cells

Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway

Silence Yes-associated Protein Expression Inhibit the Invasion Ability of Hepatocellular Carcinoma Cells

Integrated Analysis of Transcriptomics and Metabolomics in Human Hepatocellular Carcinoma HepG2215 Cells after YAP1 Knockdown

Yes-associated Protein: A Novel Molecular Target for the Diagnosis, Treatment and Prognosis of Hepatocellular Carcinoma

Yes-associated protein (YAP) increases chemosensitivity of hepatocellular carcinoma cells by modulation of p53.

Long Non-Coding RNA LOC107985656 Represses the Proliferation of Hepatocellular Carcinoma Cells Through Activation of the Tumor-Suppressive Hippo Pathway.

Integrin Α2β1 Inhibits MST1 Kinase Phosphorylation and Activates Yes-associated Protein Oncogenic Signaling in Hepatocellular Carcinoma.

Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice

YAP is overexpressed in clear cell renal cell carcinoma and its knockdown reduces cell proliferation and induces cell cycle arrest and apoptosis.

Yes-associated Protein Expression is a Predictive Marker for Recurrence of Hepatocellular Carcinoma after Liver Transplantation.

RETRACTED: YAP1 Inhibition in HUVECs is Associated with Released Exosomes and Increased Hepatocarcinoma Invasion and Metastasis

Interaction Of S100a1 With Lats1 Promotes Cell Growth Through Regulation Of The Hippo Pathway In Hepatocellular Carcinoma

Overexpression of Yes-Associated Protein Contributes to Progression and Poor Prognosis of Non-Small-cell Lung Cancer.

Yes-associated protein (YAP) binds to HIF-1α and sustains HIF-1α protein stability to promote hepatocellular carcinoma cell glycolysis under hypoxic stress

pVHL promotes lysosomal degradation of YAP in lung adenocarcinoma

Effect of silencing of Yes-associated protein 1 gene on proliferation and invasion of human non-small cell lung cancer cells

Yes-Associated Protein 1 Promotes Adenocarcinoma Growth and Metastasis Through Activation of the Receptor Tyrosine Kinase Axl